CN Patent

CN102670544A — 一种拉科酰胺缓释片及其制备方法

Assigned to Shijiazhuang No 4 Pharmaceutical Co Ltd · Expires 2012-09-19 · 14y expired

What this patent protects

本发明涉及一种拉科酰胺缓释片及其制备方法，本发明的缓释片由拉科酰胺、缓释材料以及其他辅料组成。其中拉科酰胺占片剂重量的5％～90％，缓释材料占片剂重量的4％～90％，其中所述缓释材料包括：一种羟丙甲基纤维素或多种羟丙甲基纤维素的混合物。

USPTO Abstract

本发明涉及一种拉科酰胺缓释片及其制备方法，本发明的缓释片由拉科酰胺、缓释材料以及其他辅料组成。其中拉科酰胺占片剂重量的5％～90％，缓释材料占片剂重量的4％～90％，其中所述缓释材料包括：一种羟丙甲基纤维素或多种羟丙甲基纤维素的混合物。

Drugs covered by this patent

Vimpat (lacosamide) · UCB

Patent Metadata

Patent number: CN102670544A
Jurisdiction: CN
Classification: —
Expires: 2012-09-19
Drug substance claim: No
Drug product claim: No
Assignee: Shijiazhuang No 4 Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.